Inception Return
(10/28/2013)
|
7.39 %
|
|
YTD Return
|
4.84 %
|
|
NAVPS
(4/24/2024)
|
$20.59
|
|
Change
|
$0.01 / 0.07 %
|
|
|
Growth of $10,000
(As of March 31, 2024)
|
|
MER
|
2.06 %
|
|
Assets ($mil)
|
$458.29
|
|
Rank (1Yr)
|
119/1038
|
|
Std Dev (3Yr)
|
10.65 %
|
|
Volatility Ranking (3Yr)
|
5/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Choice of Front or No Load
|
|
Max Front End
|
5.00 %
|
|
Max Back End
|
5.50 %
|
|
Sales Status
|
Partially Open
|
|
|
Objective
The Fund seeks to provide a combination of income and capital appreciation by investing primarily in a diversified portfolio of dividend paying equity securities and fixed income securities.
|
Fund Manager
Manulife Investment Management Limited
Portfolio Manager
Christopher Chapman, Manulife Investment Management Limited
Sub-Advisor
Michael J. Mattioli, Manulife Investment Management (US) LLC
Daniel S. Janis III, Manulife Investment Management (US) LLC
Thomas C. Goggins, Manulife Investment Management (US) LLC
Dennis F. McCafferty, Manulife Investment Management (US) LLC
Emory (Sandy) W. Sanders, Manulife Investment Management (US) LLC
Manulife Investment Management (Europe) Limited
Kisoo Park, Manulife Investment Management (Hong Kong) Limited
|
|
Asset Allocation
(As of February 29, 2024)
|
Sector Allocation
(As of February 29, 2024)
|
Geographic Allocation
(As of February 29, 2024)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| KKR & Co Inc | US Equity | Financial Services | United States | 0.00% |
| Crown Castle International Corp | US Equity | Real Estate | United States | 0.00% |
| Apple Inc | US Equity | Technology | United States | 0.00% |
| Anthem Inc | US Equity | Healthcare | United States | 0.00% |
| GSK plc - ADR | International Equity | Healthcare | European Union | 0.00% |
| Lennar Corp Cl A | US Equity | Real Estate | United States | 0.00% |
| Cellnex Telecom SA | International Equity | Telecommunications | European Union | 0.00% |
| Danone SA | International Equity | Consumer Goods | European Union | 0.00% |
| Nasdaq Inc | US Equity | Financial Services | United States | 0.00% |
| Elanco Animal Health Inc | US Equity | Healthcare | United States | 0.00% |
Performance Data
(As of March 31, 2024)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
2.35
|
4.84
|
14.56
|
4.84
|
12.84
|
5.98
|
6.97
|
6.79
|
|
Benchmark
|
1.80
|
5.77
|
13.57
|
5.77
|
12.38
|
3.87
|
5.64
|
7.01
|
|
Quartile Ranking
|
1
|
2
|
1
|
2
|
1
|
1
|
1
|
1
|
|
Calendar Return (%)
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
|
Fund
|
14.00
|
-9.95
|
14.30
|
4.19
|
20.61
|
-10.10
|
9.81
|
9.77
|
6.00
|
13.50
|
|
Benchmark
|
11.69
|
-11.62
|
6.48
|
11.12
|
12.26
|
2.68
|
8.66
|
2.39
|
17.05
|
12.44
|
|
Quartile Ranking
|
1
|
2
|
1
|
4
|
1
|
4
|
1
|
1
|
1
|
1
|